FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119340881> ?p ?o ?g. }

• W2119340881 endingPage "165" @default.
• W2119340881 startingPage "160" @default.
• W2119340881 abstract "Summary Cancer increases the risk of venous thromboembolism (VTE). Here, we investigated the contribution of microparticle (MP)-dependent procoagulant activity to the prothrombotic state in these patients. In 43 cancer patients without VTE at study entry and 22 healthy volunteers, markers of in vivo and MP-dependent coagulation were measured and patients were prospectively followed for six months for the development of VTE. Procoagulant activity of MPs was measured in vitro using a tissue factor (TF)-independent phospholipid dependent test, a factor Xa-generation assay with and without anti-TF, and a fibrin generation test (FGT) with and without anti-factor VII(a). Markers of in vivo coagulation activation and total number of MPs at baseline were significantly elevated in cancer patients compared to controls (F1+2 246 vs. 156 pM, thrombin-antithrombin complexes 4.1 vs. 3.0 mg/l, D-dimer 0.76 vs. 0.22 mg/l and 5.53 x 106 vs. 3.37 x 106 MPs/ml). Five patients (11.6%) developed VTE. Patients with VTE had comparable levels of coagulation activation markers and phospholipid-dependent MP pro-coagulant activity. However, median TF-mediated Xa-generation (0.82 vs. 0.21 pg/ml, p=0.016) and median VIIa-dependent FGT (13% vs. 0%, p=0.036) were higher in the VTE group compared with the non-VTE group. In this exploratory study the overall hypercoagulable state in cancer patients was not associated directly with the MP phospholipid-dependent procoagulant activity. However, in the patients who developed VTE within six months when compared to those who did not, an increased MP procoagulant activity was present already at baseline, suggesting this activity can be used to predict VTE." @default.
• W2119340881 created "2016-06-24" @default.
• W2119340881 creator A5003239706 @default.
• W2119340881 creator A5006968262 @default.
• W2119340881 creator A5020475778 @default.
• W2119340881 creator A5039749055 @default.
• W2119340881 creator A5042290277 @default.
• W2119340881 creator A5042857630 @default.
• W2119340881 creator A5049728223 @default.
• W2119340881 creator A5052679896 @default.
• W2119340881 creator A5055422464 @default.
• W2119340881 creator A5075629445 @default.
• W2119340881 date "2012-01-01" @default.
• W2119340881 modified "2023-09-27" @default.
• W2119340881 title "Coagulation activation and microparticle-associated coagulant activity in cancer patients" @default.
• W2119340881 cites W1727122499 @default.
• W2119340881 cites W1967618170 @default.
• W2119340881 cites W1980874014 @default.
• W2119340881 cites W2003714769 @default.
• W2119340881 cites W2012535096 @default.
• W2119340881 cites W2015962018 @default.
• W2119340881 cites W2028007287 @default.
• W2119340881 cites W2028513701 @default.
• W2119340881 cites W2044540189 @default.
• W2119340881 cites W2051959397 @default.
• W2119340881 cites W2053312442 @default.
• W2119340881 cites W2059215414 @default.
• W2119340881 cites W2080836382 @default.
• W2119340881 cites W2086458592 @default.
• W2119340881 cites W2090621693 @default.
• W2119340881 cites W2117890823 @default.
• W2119340881 cites W2129464080 @default.
• W2119340881 cites W2141702039 @default.
• W2119340881 cites W2147948743 @default.
• W2119340881 cites W2154344198 @default.
• W2119340881 cites W2163438647 @default.
• W2119340881 doi "https://doi.org/10.1160/th12-02-0099" @default.
• W2119340881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22535219" @default.
• W2119340881 hasPublicationYear "2012" @default.
• W2119340881 type Work @default.
• W2119340881 sameAs 2119340881 @default.
• W2119340881 citedByCount "82" @default.
• W2119340881 countsByYear W21193408812012 @default.
• W2119340881 countsByYear W21193408812013 @default.
• W2119340881 countsByYear W21193408812014 @default.
• W2119340881 countsByYear W21193408812015 @default.
• W2119340881 countsByYear W21193408812016 @default.
• W2119340881 countsByYear W21193408812017 @default.
• W2119340881 countsByYear W21193408812018 @default.
• W2119340881 countsByYear W21193408812019 @default.
• W2119340881 countsByYear W21193408812020 @default.
• W2119340881 countsByYear W21193408812021 @default.
• W2119340881 countsByYear W21193408812022 @default.
• W2119340881 countsByYear W21193408812023 @default.
• W2119340881 crossrefType "journal-article" @default.
• W2119340881 hasAuthorship W2119340881A5003239706 @default.
• W2119340881 hasAuthorship W2119340881A5006968262 @default.
• W2119340881 hasAuthorship W2119340881A5020475778 @default.
• W2119340881 hasAuthorship W2119340881A5039749055 @default.
• W2119340881 hasAuthorship W2119340881A5042290277 @default.
• W2119340881 hasAuthorship W2119340881A5042857630 @default.
• W2119340881 hasAuthorship W2119340881A5049728223 @default.
• W2119340881 hasAuthorship W2119340881A5052679896 @default.
• W2119340881 hasAuthorship W2119340881A5055422464 @default.
• W2119340881 hasAuthorship W2119340881A5075629445 @default.
• W2119340881 hasConcept C121608353 @default.
• W2119340881 hasConcept C126322002 @default.
• W2119340881 hasConcept C150903083 @default.
• W2119340881 hasConcept C186738567 @default.
• W2119340881 hasConcept C203014093 @default.
• W2119340881 hasConcept C207001950 @default.
• W2119340881 hasConcept C2777151630 @default.
• W2119340881 hasConcept C2777557582 @default.
• W2119340881 hasConcept C2778382381 @default.
• W2119340881 hasConcept C2778589496 @default.
• W2119340881 hasConcept C2779026020 @default.
• W2119340881 hasConcept C2780011451 @default.
• W2119340881 hasConcept C2780868729 @default.
• W2119340881 hasConcept C2780930249 @default.
• W2119340881 hasConcept C54173615 @default.
• W2119340881 hasConcept C71924100 @default.
• W2119340881 hasConcept C86803240 @default.
• W2119340881 hasConcept C90924648 @default.
• W2119340881 hasConceptScore W2119340881C121608353 @default.
• W2119340881 hasConceptScore W2119340881C126322002 @default.
• W2119340881 hasConceptScore W2119340881C150903083 @default.
• W2119340881 hasConceptScore W2119340881C186738567 @default.
• W2119340881 hasConceptScore W2119340881C203014093 @default.
• W2119340881 hasConceptScore W2119340881C207001950 @default.
• W2119340881 hasConceptScore W2119340881C2777151630 @default.
• W2119340881 hasConceptScore W2119340881C2777557582 @default.
• W2119340881 hasConceptScore W2119340881C2778382381 @default.
• W2119340881 hasConceptScore W2119340881C2778589496 @default.
• W2119340881 hasConceptScore W2119340881C2779026020 @default.
• W2119340881 hasConceptScore W2119340881C2780011451 @default.
• W2119340881 hasConceptScore W2119340881C2780868729 @default.
• W2119340881 hasConceptScore W2119340881C2780930249 @default.
• W2119340881 hasConceptScore W2119340881C54173615 @default.

• next